Clinical trial
A Prospective, Interventional, Repeated Measures Feasibility Study to Evaluate Change in Tinnitus Severity for Adult Recipients of a Totally Implantable Cochlear Implant System Who Experience Tinnitus Pre-Operatively
NCT07893860 is registered in ClinicalTrials.gov with Cochlear as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Interventional, Repeated Measures Feasibility Study to Evaluate Change in Tinnitus Severity for Adult Recipients of a Totally Implantable Cochlear Implant System Who Experience Tinnitus Pre-Operatively
- Lead sponsor
- Cochlear
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- February 28, 2027
- Completion date
- April 30, 2028
- Enrollment
- 14 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
sensorineural hearing loss, tinnitus
Arms
As registered; 1 arm.
-
Totally Implantable Cochlear Implant System
Participants will be implanted with the TI1132 implant
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Evaluate the impact of the TICI G2 Clinical Investigation System usage on Tinnitus Handicap Inventory (THI) ratings
Mean within-subject change in THI score. The THI measures tinnitus severity. The score ranges from Slight or No handicap (Grade 1): 0-16, Mild (Grade 2): 18-36, Moderate (Grade 3): 38-56, Severe (Grade 4): 58-76 to Catastrophic (Grade 5): 78-100
Lead sponsor's other trials
Cochlear, most recent start first.
+86 more trials
Similar trials
Same condition (Tinnitus) and phase, most recent start first.
+260 more trials See the condition page